Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Personal Products Industry Analysis

UpdatedApr 02, 2026
DataAggregated Company Financials
Companies113
  • 7D-1.8%
  • 3M-16.7%
  • 1Y-20.9%
  • YTD-17.6%

Over the last 7 days, the Personal Products industry has dropped 1.8%, driven by a pullback from Estée Lauder Companies of 3.3%. In contrast, Olaplex Holdings has gained 53%. Overall the industry is down 21% in 12 months. Earnings are forecast to grow by 30% annually.

Industry Valuation and Performance

Has the U.S. Personal Products Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 02 Apr 2026US$75.0bUS$48.2bUS$669.7m21.4x112x1.6x
Sat, 28 Feb 2026US$96.2bUS$48.2bUS$839.5m21x114.6x2x
Mon, 26 Jan 2026US$97.2bUS$47.6bUS$350.1m22.8x277.5x2x
Wed, 24 Dec 2025US$90.9bUS$47.6bUS$351.4m22.7x258.5x1.9x
Fri, 21 Nov 2025US$79.8bUS$47.6bUS$558.0m21.6x143x1.7x
Sun, 19 Oct 2025US$91.3bUS$47.7bUS$307.9m20.2x296.5x1.9x
Tue, 16 Sep 2025US$94.1bUS$47.6bUS$304.0m21.4x309.4x2x
Thu, 14 Aug 2025US$101.7bUS$48.1bUS$562.2m21x180.9x2.1x
Sat, 12 Jul 2025US$99.1bUS$48.0bUS$109.5m17.8x905.6x2.1x
Mon, 09 Jun 2025US$94.7bUS$48.0bUS$127.3m17.2x743.8x2x
Wed, 07 May 2025US$90.5bUS$48.3bUS$375.0m21.9x241.3x1.9x
Fri, 04 Apr 2025US$93.2bUS$48.7bUS$556.6m22.7x167.5x1.9x
Sun, 02 Mar 2025US$95.4bUS$49.0bUS$328.5m26.9x290.4x1.9x
Tue, 28 Jan 2025US$98.5bUS$49.3bUS$1.5b26.1x66.8x2x
Thu, 26 Dec 2024US$98.5bUS$49.3bUS$1.5b27.8x66.7x2x
Sat, 23 Nov 2024US$100.3bUS$49.3bUS$1.5b28.5x68.1x2x
Mon, 21 Oct 2024US$103.5bUS$49.5bUS$1.6b26.7x64x2.1x
Wed, 18 Sep 2024US$107.3bUS$49.5bUS$1.6b21.8x65.5x2.2x
Fri, 16 Aug 2024US$106.9bUS$49.2bUS$2.0b18x54x2.2x
Sun, 14 Jul 2024US$111.6bUS$49.0bUS$2.4b21.5x46.1x2.3x
Tue, 11 Jun 2024US$113.0bUS$49.0bUS$2.4b23.3x46.6x2.3x
Thu, 09 May 2024US$120.1bUS$48.9bUS$2.5b24.8x49x2.5x
Sat, 06 Apr 2024US$126.0bUS$48.8bUS$2.5b25.8x49.7x2.6x
Mon, 04 Mar 2024US$130.4bUS$49.0bUS$2.5b30.4x53x2.7x
Wed, 31 Jan 2024US$127.7bUS$50.1bUS$2.6b27.1x50.1x2.5x
Fri, 29 Dec 2023US$129.7bUS$49.9bUS$2.6b23.9x49.3x2.6x
Sun, 26 Nov 2023US$114.8bUS$49.9bUS$2.6b24x44.1x2.3x
Tue, 24 Oct 2023US$115.8bUS$50.0bUS$3.3b23.6x35.4x2.3x
Thu, 21 Sep 2023US$126.9bUS$50.0bUS$3.3b23.5x38.6x2.5x
Sat, 19 Aug 2023US$134.8bUS$49.8bUS$3.0b21.2x44.3x2.7x
Mon, 17 Jul 2023US$150.3bUS$49.3bUS$3.1b22x47.9x3x
Wed, 14 Jun 2023US$147.0bUS$49.3bUS$3.1b21.6x46.9x3x
Fri, 12 May 2023US$153.0bUS$48.9bUS$3.3b19.3x46.7x3.1x
Sun, 09 Apr 2023US$118.9bUS$34.5bUS$1.7b17.7x70.9x3.4x
Price to Earnings Ratio

70.9x


Total Market Cap: US$118.9bTotal Earnings: US$1.7bTotal Revenue: US$34.5bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Personal Products Industry Price to Earnings3Y Average 167.8x202420252026
Current Industry PE
  • Investors are pessimistic on the American Personal Products industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 112x which is lower than its 3-year average PE of 168x.
  • The 3-year average PS ratio of 2.3x is higher than the industry's current PS ratio of 1.6x.
Past Earnings Growth
  • The earnings for companies in the Personal Products industry have declined 26% per year over the last three years.
  • Meanwhile revenues for these companies have grown 12% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Consumer Staples industry?

US Market-0.32%
Consumer Staples0.93%
Personal Products-1.83%
Personal Products-1.83%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
OLPX Olaplex HoldingsUS$2.0352.6%
+US$473.3m		53.8%PS3.2x
EPC Edgewell Personal CareUS$21.316.2%
+US$57.9m		-32.8%PE158x
IPAR InterparfumsUS$92.541.4%
+US$41.1m		-19.2%PE17.6x
BRBR BellRing BrandsUS$15.640.9%
+US$16.4m		-79.7%PE10x
NATR Nature's Sunshine ProductsUS$24.472.9%
+US$12.3m		97.5%PE21.9x

Latest News

HLF
US$14.39
Herbalife
7D
-5.9%
1Y
63.0%
ELF
US$62.30
e.l.f. Beauty
7D
-10.6%
1Y
-8.2%

ELF: Market Share Gains And Raised Sales Outlook Will Support Upside

Analysts have trimmed their average price target on e.l.f. Beauty by about $2. This reflects updated views on slightly softer revenue growth and profit margins, partly offset by a higher assumed future P/E multiple and ongoing mixed signals in recent sales and consumption data.
EPC
US$21.31
Edgewell Personal Care
7D
6.2%
1Y
-32.8%

EPC: Margin Improvement And Revised EPS Outlook Will Drive Attractive Returns

Analysts have modestly adjusted their price target on Edgewell Personal Care to $24.33. The revised target reflects updated assumptions around the discount rate, revenue trajectory, profit margins, and future P/E expectations.
NATR
US$24.47
Nature's Sunshine Products
7D
2.9%
1Y
97.5%
EL
US$70.71
Estée Lauder Companies
7D
-3.3%
1Y
2.8%

EL: Potential Puig Deal And New Fragrance Launch Will Support Future Upside

Analysts have trimmed their price targets for Estée Lauder Companies to around $106, reflecting slightly softer revenue growth assumptions, a marginally higher discount rate and a somewhat lower future P/E multiple, partly balanced by modestly stronger profit margin expectations. What's in the News Estée Lauder and Spanish beauty group Puig confirmed on March 23, 2026 that they are in discussions over a potential business combination that could create a company valued at more than US$40b, with no final agreement in place and no assurance that a transaction will occur (company statements, FT report).
KVUE
US$17.38
Kenvue
7D
-1.6%
1Y
-27.2%
IPAR
US$92.54
Interparfums
7D
1.4%
1Y
-19.2%

IPAR: Asset Light Model Will Benefit From New Long Term Fragrance Licenses

Analysts lifted their price target on Interparfums to $111.20 per share, supported by updated assumptions for a slightly lower discount rate, consistent revenue growth of 6.12%, stable profit margin of 11.19%, and a refined future P/E of 21.28x. Analyst Commentary Bullish Takeaways Bullish analysts see the refined future P/E of 21.28x as consistent with the company’s earnings profile, given the working assumptions around revenue growth and margins, rather than stretched for the sector.
OLPX
US$2.03
Olaplex Holdings
7D
52.6%
1Y
53.8%
WALD
US$0.91
Waldencast
7D
-19.5%
1Y
-69.4%
NUS
US$7.36
Nu Skin Enterprises
7D
1.0%
1Y
3.2%
MED
US$10.10
Medifast
7D
5.3%
1Y
-26.1%

MED: Future Leadership Shift Will Seek To Unlock Metabolic Health Opportunity

Analysts have slightly revised their price target on Medifast, with the updated fair value holding at $12.00 as small adjustments to the discount rate and future P/E assumptions refine the underlying model rather than indicate a major change in outlook. What's in the News OPTAVIA’s comprehensive metabolic health system is now eligible for reimbursement on select insurance plans via HSA and FSA funds, which can allow some clients to use pre tax dollars toward program costs (Product related announcement).
HNST
US$2.78
Honest Company
7D
-5.1%
1Y
-44.4%

HNST: Consistent Execution And Buyback Program Will Shape Transformation 2.0 Outlook

Analysts have trimmed Honest Company's average price target by about $1 to align with revised firm targets of $5 and $3.50, citing slightly soft Q4 results, the need for several quarters of consistent execution, and a longer timeline before the business outlook becomes clearer. Analyst Commentary Bearish analysts are resetting expectations on Honest Company, trimming price targets and flagging a longer wait before the story becomes clearer.
BRBR
US$15.64
BellRing Brands
7D
0.9%
1Y
-79.7%

BRBR: Protein Adoption And Reset Expectations Will Shape Future Upside Potential

BellRing Brands' fair value estimate has shifted from $50.00 to $35.00 as analysts recalibrate price targets across the group, citing softer recent volume data, a reset in assumed future P/E multiples, and a more measured stance on competition, even as they still point to growing mainstream demand for convenient protein shakes and snacks. Analyst Commentary Recent Street research on BellRing Brands points to a mixed but still constructive backdrop, with several bullish analysts highlighting the broader protein theme and the company's role in it, even as price targets reset lower.
ODD
US$13.40
Oddity Tech
7D
-3.4%
1Y
-71.9%

ODD: Advertising Algorithm Reset Will Eventually Restore Customer Acquisition Efficiency

Analysts have sharply reduced the consolidated price target for Oddity Tech to about $29.17 from $90, reflecting concerns around higher customer acquisition costs, weaker visibility after the recent ad platform disruptions, and more conservative assumptions for revenue growth, profit margins, and future P/E multiples. Analyst Commentary Street research has shifted sharply more cautious on Oddity Tech, with multiple firms cutting price targets and moving ratings to more neutral or negative stances.
UPXI
US$0.99
Upexi
7D
-17.0%
1Y
-55.1%
ELAB
US$14.00
PMGC Holdings
7D
669.2%
1Y
-96.3%